News

Regeneron Pharmaceuticals is set to acquire 23andMe for $256 million following its bankruptcy filing due to declining demand ...
Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...
The Moody’s announcement sent the yield on a 30-year Treasury bond to a high of 5.01% at one point on Monday. Bond yields ...
Regeneron to rescue 23andMe in a $256 million deal, raising major questions about DNA privacy, genetic data ownership, and ...
The latest warnings from JPMorgan’s Jamie Dimon on geopolitical risks and tariffs have become par for the course.While he ...
Home Depot doesn’t expect to raise prices because of tariffs, saying it has spent years diversifying the sources for the ...
Wall Street stocks edged higher Monday (May 19) after shrugging off a spike in US Treasury bond yields following Moody's ...
Morning! Today we start with some breaking newss: Novo Nordisk’s CEO is stepping down. We also discuss a new, tailored CRISPR treatment for an infant with a deadly disease, how Amgen owes Regeneron ...
Tech losses halted the S&P 500’s rally as Dow and Nasdaq also fell. Investors brace for inflation data and Fed signals to ...
The FTSE 100 , US markets and European stocks floundered on Monday, despite a new deal struck between the EU and UK, as ...
On May 8, 2025, the Boston Bar Association hosted its annual White Collar Crime Conference, a reoccurring theme of which was ...
The US’s credit rating took a hit on Friday, after Moody’s downgraded the country’s AAA rating. And then yesterday, bond prices followed suit. Here to explain the significance of these market moves is ...